Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$120,000.00
Investigating sensory dysfunction in autism spectrum disorder using cortical and thalamic organoids as models
EF 2024-25
Résumé
Autism spectrum disorder (ASD) is a group of brain disorders that are characterized by abnormalities in social communication and repetitive, restricted behaviors. Up to 95% of children with ASD have deficits in processing environmental sensory information. These deficits may be expressed as heightened reactions or diminished responses to sensory stimuli, such as increased sensitivity to sounds or a seemingly unaffected response to pain or temperature. Alterations to specific regions of DNA that are involved in the development of the brain have been linked to ASD and sensory-related deficits. Specifically, mice that have errors in DNA regions known as Fmr1 and Cyfip1 display sensory and behavioural deficits observed in ASD patients. The proteins Fmr1 and Cyfip1 typically work together with other complex machinery to control the production of important proteins that are required for electrical communication between brain cells. Studies in rodents are limited because of key differences between animal and human neurodevelopment such as cell organization. This highlights a valuable and significant need for human models to mimic key aspects of the developing human brain. Human pluripotent stem cells are cells that have the potential to turn into any cell of the body. With the addition of specific drug intermediates, we can use these cells to generate artificial 3-dimensional cellular structures, known as brain organoids. In my project, I will use region-specific brain organoids as a model to understand the link between changes in brain protein levels caused by Fmr1 and Cyfip1 deficiency, how this can affect the development of the brain and ultimately, result in sensory deficits. The findings of this research will clarify how deficiency in Fmr1 and Cyfip1 contributes to sensory deficits in ASD and will aid in understanding complex pathways that can be targeted by drug therapeutics for treatment
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
518286
Name
Geahchan Sarah
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating sensory dysfunction in autism spectrum disorder using cortical and thalamic organoids as models
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Autism Spectrum Disorder; Genetics; Human Stem Cells; Neurodevelopment; Neuroscience; Organoids; Sensory Dysfunction
Abstract
Autism spectrum disorder (ASD) is a group of brain disorders that are characterized by abnormalities in social communication and repetitive, restricted behaviors. Up to 95% of children with ASD have deficits in processing environmental sensory information. These deficits may be expressed as heightened reactions or diminished responses to sensory stimuli, such as increased sensitivity to sounds or a seemingly unaffected response to pain or temperature. Alterations to specific regions of DNA that are involved in the development of the brain have been linked to ASD and sensory-related deficits. Specifically, mice that have errors in DNA regions known as Fmr1 and Cyfip1 display sensory and behavioural deficits observed in ASD patients. The proteins Fmr1 and Cyfip1 typically work together with other complex machinery to control the production of important proteins that are required for electrical communication between brain cells. Studies in rodents are limited because of key differences between animal and human neurodevelopment such as cell organization. This highlights a valuable and significant need for human models to mimic key aspects of the developing human brain. Human pluripotent stem cells are cells that have the potential to turn into any cell of the body. With the addition of specific drug intermediates, we can use these cells to generate artificial 3-dimensional cellular structures, known as brain organoids. In my project, I will use region-specific brain organoids as a model to understand the link between changes in brain protein levels caused by Fmr1 and Cyfip1 deficiency, how this can affect the development of the brain and ultimately, result in sensory deficits. The findings of this research will clarify how deficiency in Fmr1 and Cyfip1 contributes to sensory deficits in ASD and will aid in understanding complex pathways that can be targeted by drug therapeutics for treatment
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Geahchan, Sarah
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~